Elan jumps on Biogen bid report
104489
Shares in pharmaceutical company Elan soared in early trading this morning after a newspaper report that US company Biogen was considering a bid for the company.
633781
Schering-Plough said that second-quarter earnings rose sharply, fueled by growing demand for its Zetia and Vytorin cholesterol drugs and treatments for arthritis and allergies.
683001
Patients taking an experimental multiple sclerosis drug developed by Biogen Idec Inc.  and Elan Corp.  experienced far fewer relapses in a clinical trial, data that analysts say could give the drug a dominant market position.
59608
Standard &amp; Poor&#39;s Equity Research reiterated a &quot;hold&quot; rating and $68 target price on Biogen Idec (nasdaq: BIIB - news - people ), saying the anticipated success of the company&#39;s Antegren drug is largely factored into the share price.
322638
Epoch Biosciences, a small Bothell company that makes tools to speed up genetic analysis, said yesterday it has agreed to be sold to San Diego-based Nanogen for about $60 million in stock.
304071
Biogen releases its third-quarter financial results.
621805
First Albany Capital on Wednesday raised SuperGen Inc.&#39;s (SUPG.O: Quote, Profile, Research) stock rating to &quot;buy&quot; from &quot;neutral,&quot; following its cancer-drug deal with MGI Pharma Inc.
142092
SAN FRANCISCO (CBS.MW) -- Shares of Elan Corp. and Biogen Idec rose in after-hours trading Tuesday after Tysabri, a drug used for the treatment of multiple sclerosis, was approved by the US Food and Drug Administration.
723657
Could a jointly marketed drug lead to a joint company? Ireland&#39;s Sunday Tribune said yesterday that US pharmaceuticals company Biogen Idec (nasdaq: BIIB - news - people ) was looking to make an all-stock bid
484759
Black Sea resorts, fuel retailer Petrol and veterinary drug maker Biovet rallied Monday pushing Bulgaria's stock index SOFIX 1.67 points or 0.28% up to 607.24 points.
732695
The stock of biotechnology company Biomira (Nasdaq: BIOM), a research and development company specializing in cancer, shot up 146% (to $3.77 a share) from yesterday&#39;s closing price after the company
677224
Shares in Barclays  climbed for a second day on Friday as speculation mounted that Bank of America  could bid for the UK bank, with a leading analyst saying there could be strong merit to an acquisition.
513506
Multiple bids could drive the company's stock even higher.
687993
Business & money: 9.30am: Shares in the bank jumped almost 3% after recommendation.
432855
Biogen Idec in Cambridge is rumored to be in talks to buy or merge with Elan Corp. in Ireland, though the later company denies any such conversation is taking place, Bloomberg News is reporting.
382650
LONDON/BEIJING  - British bank Barclays raised its bid for Dutch group ABN AMRO to 67.5 billion euros ($93 billion) on Monday, helped by some of the biggest ever overseas investments by China and Singapore.
608954
Shares in German postal bank Deutsche Postbank leapt higher Wednesday amid fresh takeover and merger speculation sparked by a press report early in the day.